| Michael F Soboeiro, MD | |
|
205 Page Rd, Pinehurst, NC 28374-8798 | |
| (910) 295-5511 | |
| (910) 235-3418 |
| Full Name | Michael F Soboeiro |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 33 Years |
| Location | 205 Page Rd, Pinehurst, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134164304 | NPI | - | NPPES |
| 0403982 | Other | NC | EVERCARE |
| FH1000920 | Other | NC | FIRSTCAROLINACARE PROV# |
| 78425 | Other | NC | BCBS |
| 98438 | Other | NC | MEDCOST PROVIDER# |
| 110205345 | Other | NC | PALMETTO GBA PROVIDER# |
| N0035A | Other | SC | SC MEDICAID PROVIDER# |
| 7978425 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 9400359 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wakemed, Raleigh Campus | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advance Community Health Inc | 3577471697 | 20 |
| Wake Specialty Physicians Llc | 7416006085 | 144 |
News Archive
Readmission of patients with chronic diseases is a growing problem, costing the U.S. health care system about $25 billion each year. Researchers at The University of Texas at Dallas developed a predictive analytics model that can identify congestive heart failure patients with high readmission risk and potentially help stymie those costs.
Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.
Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
A new study from Beth Israel Deaconess Medical Center (BIDMC) has proved the cost-effectiveness and life-saving potential of the "polypill": a single new pill which combines four commonly prescribed cardiovascular drugs into one to prevent a recurrent stroke or heart event in adult patients in low- and middle-income countries (LMIC).
› Verified 4 days ago
| Entity Name | Advance Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245223783 PECOS PAC ID: 3577471697 Enrollment ID: O20040824000695 |
News Archive
Readmission of patients with chronic diseases is a growing problem, costing the U.S. health care system about $25 billion each year. Researchers at The University of Texas at Dallas developed a predictive analytics model that can identify congestive heart failure patients with high readmission risk and potentially help stymie those costs.
Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.
Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
A new study from Beth Israel Deaconess Medical Center (BIDMC) has proved the cost-effectiveness and life-saving potential of the "polypill": a single new pill which combines four commonly prescribed cardiovascular drugs into one to prevent a recurrent stroke or heart event in adult patients in low- and middle-income countries (LMIC).
› Verified 4 days ago
| Entity Name | Wake Specialty Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942440375 PECOS PAC ID: 7416006085 Enrollment ID: O20090601000520 |
News Archive
Readmission of patients with chronic diseases is a growing problem, costing the U.S. health care system about $25 billion each year. Researchers at The University of Texas at Dallas developed a predictive analytics model that can identify congestive heart failure patients with high readmission risk and potentially help stymie those costs.
Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.
Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
A new study from Beth Israel Deaconess Medical Center (BIDMC) has proved the cost-effectiveness and life-saving potential of the "polypill": a single new pill which combines four commonly prescribed cardiovascular drugs into one to prevent a recurrent stroke or heart event in adult patients in low- and middle-income countries (LMIC).
› Verified 4 days ago
| Entity Name | Advance Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952760290 PECOS PAC ID: 3577471697 Enrollment ID: O20210119000168 |
News Archive
Readmission of patients with chronic diseases is a growing problem, costing the U.S. health care system about $25 billion each year. Researchers at The University of Texas at Dallas developed a predictive analytics model that can identify congestive heart failure patients with high readmission risk and potentially help stymie those costs.
Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.
Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
A new study from Beth Israel Deaconess Medical Center (BIDMC) has proved the cost-effectiveness and life-saving potential of the "polypill": a single new pill which combines four commonly prescribed cardiovascular drugs into one to prevent a recurrent stroke or heart event in adult patients in low- and middle-income countries (LMIC).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael F Soboeiro, MD 205 Page Rd, Pinehurst, NC 28374-8798 Ph: (910) 295-5511 | Michael F Soboeiro, MD 205 Page Rd, Pinehurst, NC 28374-8798 Ph: (910) 295-5511 |
News Archive
Readmission of patients with chronic diseases is a growing problem, costing the U.S. health care system about $25 billion each year. Researchers at The University of Texas at Dallas developed a predictive analytics model that can identify congestive heart failure patients with high readmission risk and potentially help stymie those costs.
Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.
Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.
Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel — called colorectal metachronous adenomas — in people who previously had colorectal polyps removed.
A new study from Beth Israel Deaconess Medical Center (BIDMC) has proved the cost-effectiveness and life-saving potential of the "polypill": a single new pill which combines four commonly prescribed cardiovascular drugs into one to prevent a recurrent stroke or heart event in adult patients in low- and middle-income countries (LMIC).
› Verified 4 days ago
Michael A Pritchett, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Page Road, Pinehurst, NC 28374 Phone: 910-295-9359 Fax: 910-235-3401 | |
Bobby R Maynor Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Regional Dr, Pinehurst, NC 28374 Phone: 910-255-4400 Fax: 910-420-1604 | |
Francis Farrell Collins Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Page Rd, Pinehurst, NC 28374 Phone: 910-295-9359 Fax: 910-235-3419 | |
Kristina Maria Catania, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-7984 | |
Dr. Scott D Skibo, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 Page Rd, Pinehurst, NC 28374 Phone: 102-955-5119 Fax: 910-235-3421 | |
David F Martin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Regional Dr, Pinehurst, NC 28374 Phone: 910-295-9207 Fax: 910-235-3432 | |
Charles Samuel Kuzma, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 Page Rd, Pinehurst, NC 28374 Phone: 910-715-3500 Fax: 910-715-3501 |